Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 206 publications.

Rothman KJ, Arellano FM, Young-Xu Y, Simonsen L. Reply to gargiullo et Al. J Infect Dis. 2006 Dec 15;194(12):1794-5.

Rothman KJ, Arellano FM, Young-Xu Y, Simonsen L. Reply to "is there a safe age for vaccinating infants with tetravalent rhesus-human reassortant rotavirus vaccine?". J Infect Dis. 2006 Dec;194(12):1793-4.

Mangel AW, Fehnel SE. Adequate relief in IBS treatment trials: corrections to errors stated by Whitehead et al. Am J Gastroenterol. 2006 Dec;101(12):2884-5.

Greiner W, Lehmann K, Earnshaw S, Bug C, Sabatowski R. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany. Eur J Health Econ. 2006 Dec 1;7(4):290-6.

Seeger JD, West WA, Fernandez C, Rivero E. Pregnancy and pregnancy outcome among women with inflammatory skin diseases. Dermatology. 2006 Dec 1;214(1):32-9.

Perez-Gutthann S, Cook S, Dai W, Hirst C, Andrews E. A call for international harmonization in therapeutic risk management. Pharmacoepidemiol Drug Saf. 2006 Dec 1;15(12):839-49.

Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ. Use of Cyclo-Oxygenase 2 Inhibitors (COX-2) and prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile. Pharmacoepidemiol Drug Saf. 2006 Dec 1;15(12):861-72.

Sansom S, Lasry A, Hicks KA. The optimal allocation of HIV prevention dollars. Presented at the Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Project Officers' Meeting; December 2006.

Sunyer J, Jarvis D, Gotschi T, Garcia-Esteban R, Jacquemin B, Aguilera I, Ackerman U, de Marco R, Forsberg B, Gislason T, Heinrich J, Norback D, Villani S, Kunzli N. Chronic bronchitis and urban air pollution in an international study. Occup Environ Med. 2006 Dec;63(12):836-43. doi: 10.1136/oem.2006.027995

Hicks KA. A model for the efficient allocation of hiv prevention resources. Poster presented at the Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Project Officers' Meeting; December 2006.

Hicks KA. Making use of cost-effectiveness analysis in the community planning process: methods and tools. Presented at the Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Project Officers' Meeting; December 2006.

Sorensen HT, Pedersen L, Norgaard M, Rothman KJ, Lash TL. No excess risk of breast cancer in mothers of boys with hypospadias. Epidemiology. 2006 Nov 30;17(6):706-7.

Earnshaw SR, Joshi AV, Wilson MR, Rosand J. Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. Stroke. 2006 Nov 28;37(11):2751-8.

Gonzalez-Perez A, Fernandez-Vidaurre C, Rueda A, Rivero E, Garcia-Rodriguez LA. Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf. 2006 Nov 15;15(2):131-8.

Mauskopf JA, Brogan AJ, Smets E, Martin S. Cost-effectiveness of darunavir (TMC114)/ritonavir compared with currently available protease inhibitors in treatment-experienced HIV patients. Poster presented at the 8th International Congress on Drug Therapy in HIV Infection; November 2006.

Garcia-Esteban R, Sunyer J, Torrent M, Ribas-Fito N, Carrizo D, Grimalt JO, Anto JM. Early exposure to DDE and asthma. Poster presented at the International Conference on Environmental Epidemiology & Exposure (ISEE/ISEA); November 2006. Paris, France. [abstract] Epidemiology. 2006 Nov; 17(6):S281-2.

Zhou X, Radigue C, Allshouse AA, Gilsenan A. In Europe, how representative are overweight/obese subjects recruited via the internet? Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A326.

Javitt JC, Wolowacz SE, Roskell NS, Maciver F, Kelly S, Pleil AM, Zlateva GP. Cost-effectiveness of pegaptanib in age-related macular degeneration: the impact of differences between USA and UK health care systems. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A370.

Wolowacz SE, Roskell NS, Maciver F, Kelly S. Cost-utility analysis for pegaptanib in age-related macular degeneration in the UK: the impact of demographic and disease characteristics. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A370.

Sorensen HT, Lash T, Rothman KJ. Beyond randomized controlled trials. A critical comparison of trials with non-randomized studies. Hepatology. 2006 Nov;44(5):1075-82. doi: 10.1002/hep.21404

Burch SP, Davis KH, Fehnel SE, Nelsen AC, Hill CD, Shashidhar KH. Outcomes, impact and behavior associated with acute treatment of migraine. Poster presented at the 16th Migraine Trust International Symposium; November 2006. [abstract] Cephalalgia. 2006 Nov; 26(11):1358-403.

Earnshaw SR, Joshi AV, Wilson MR, Rosand J. Cost-effectiveness of recombinant activated factor vii in the treatment of intracerebral hemorrhage. Poster presented at the 2006 International Stroke Conference; February 17, 2006. [abstract] Stroke. 2006 Nov; 37(11):2751.

Earnshaw SR, Wilson MR, Joshi AV. Budgetary impact analysis of recombinant activated factor vii in the treatment of intracerebral hemorrhage: a US health plan perspective. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A329.

Earnshaw SR, Graham CN, Amonkar MM, Poston SA, Barr CE. Cost-effectiveness of ibandronate intravenous injection in the treatment of US women with postmenopausal osteoporosis. Poster presented at the 2006 American College of Rheumatology Scientific Meeting; November 2006.

Earnshaw SR, Pignone M, Tice J, Pletcher M. Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis. Poster presented at the Annual Meeting of the Institute for Operations Research and the Management Sciences; November 2006.

Cowell W, Amonkar M, Cooper A, Earnshaw SR, Beard SM, Lynch N, Middelhoven H. Ibandronate vs. alendrolate: a cost-effectiveness analysis using persist results. Poster presented at the 2006 American College of Rheumatology Scientific Meeting; November 2006.

Maxwell GL, Schildkraut JM, Calingaert B, Risinger JI, Dainty L, Marchbanks PA, Berchuck A, Barrett JC, Rodriguez GC. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk. Gynecol Oncol. 2006 Nov 1;103(2):535-40.

Mathews R, Leiss J, Vanderpuije A. Completion of high school among teenage mothers in North Carolina: a prospective study using maternally linked birth records. Poster presented at the 134th Annual Meeting of the American Public Health Association; November 2006.

Lee WC, Joshi AV, Brown TM, Hadker N, Sumner M, Pashos CL. Physicians' preferences toward coagulation factor concentrates in the treatment of hemophilia patients with inhibitors: a discrete choice experiment. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research; October 2006. [abstract] Value Health. 2006 Nov; 9(6):A251.

Mast TC, DeMuro-Mercon CJ, HPV Psychosocial Team. Describing the psychosocial burden of illness among women experiencing human papillomavirus-related illness or screening interventions. Poster presented at the 18th World Congress of the International Federation of Gynecology and Obstetrics; November 2006.

Bernardo M, Globe D, Kewalramani R, Masaquel CJ. Costs of anemia management in chronic disease (CKD) from the perspective of the payor, patient, and family. Poster presented at the American Society of Nephrology; November 2006.

Meads DM, McKenna SP, Doward LC. Assessing the cross-cultural comparability of the Centre for Epidemiologic Studies Depression scale (CES-D). Poster presented at the 2006 ISPOR 9th Annual European Congress; October 2006. Copenhagen, Denmark. [abstract] Value Health. 2006 Nov; 9(6):A324.

Wolowacz SE. The National Institute for Health and Clinical Excellence (NICE) Single Technology Appraisal (STA) process: an update on the first round of submissions. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006.

Candrilli SD, Davis KL, Joshi AV, Tortella BJ. Healthcare utilization and costs associated with blunt and penetrating trauma in a United States managed care population. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006.

Sculpher M, Longson C, Wolowacz SE, Khan S. The new National Institute of Health And Clinical Excellence (NICE) Single Technology Appraisal (STA) process: experience from the first round of completed appraisals. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 28, 2006. Copenhagen, Denmark.

Shearer A, Gazzard B, Graham CN, Davis EA, Mauskopf J, Kitahata M, Saag MS, Earnshaw SR. Simulation modeling of adherence and resistance on long-term outcomes in HIV. Poster presented at the Infectious Disease Society of America 44th Annual Meeting; October 15, 2006.

Beach RH, Poulos C, Pattanayak SK. Prevention and control of avian influenza: a view from the farm household. Presented at the CAES-FLP-CATPRN Joint Workshop 2006: Crises in Agriculture and Resource Sectors: Analysis of Policy Responses; October 15, 2006. Alberta.

Williams RE, DiBenedetti D, Zhou X, Fehnel SE, Clark RV. Healthcare seeking behavior among peri- and post-menopausal women: results from the US population-based mepi study. Poster presented at the 17th Annual Meeting of The North American Menopause Society; October 14, 2006.

Williams RE, DiBenedetti D, Zhou X, Fehnel SE, Clark RV. The menopause epidemiology (MEPI) study: vasomotor symptom results from a large population-based study. Poster presented at the 17th Annual Meeting of The North American Menopause Society; October 14, 2006.

Graham CN, Earnshaw SR, Smith DG, Hogue S, Gitchell J, Marsh H, Becker W, Saunders M. Assessing the impact of smoking cessation therapies on a managed care organization's budget. Poster presented at the Academy of Managed Care Pharmacy Educational Conference; October 7, 2006.

Fehnel SE, Johnston J, Kurtz C, Mangel AW. Assessing global change and symptom severity in subjects with ibs: qualitative item testing. Poster presented at the Annual Scientific Meeting of the American College of Gastroenterology; October 1, 2006.

D'Souza V, Nelson PN, Brown JY, Brown CA. Evaluation of P2Y receptor subtypes in human endothelial cells. Poster presented at the International Conference on Proteomics: "Bridging the Gap Between Gene Expression and Biological Function"; October 2006. Luxembourg.

Colosia AD, Khan SB. How to tailor your writing to meet your audience's needs. Poster presented at the 66th Annual Conference of the American Medical Writers Association; October 2006.

Jick H, Kaye JA, Russmann S, Jick SS. Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factors. Pharmacotherapy. 2006 Oct;10:1379-87.

Levine KB, Williams RE, DiBenedetti DB, Fehnel SE, Clark RV. Vulvo-Vaginal atrophy and female sexual dysfunction among post-menopausal women: results from the MEPI study. Poster presented at 17th Annual Meeting of the North American Menopause Society; October 2006. Nashville, TN. [abstract] Menopause. 2006 Oct 1; 13(6):990.

Sturmer T, Rothman KJ, Glynn RJ. Insights into different results from different causal contrasts in the presence of effect-measure modification. Pharmacoepidemiol Drug Saf. 2006 Oct 1;15(10):698-709.

Sunyer J, Torrent M, Garcia-Esteban R, Ribas-Fito N, Carrizo D, Romieu I, Anto JM, Grimalt JO. Early exposure to dichlorodiphenyldichloroethylene, breastfeeding and asthma at age six. Clin Exp Allergy. 2006 Oct;36(10):1236-41. doi: 10.1111/j.1365-2222.2006.02560.x

Beach RH, Poulos C, Pattanayak SK. The economics of preventing and controlling avian influenza. Poster presented at the CAES-FLP-CATPRN Joint Workshop 2006: Crises in Agriculture and Resource Sectors: Analysis of Policy Responses, October 15-17, 2006; October 1, 2006. Calgary, Canada.

Davis KL, Joshi AV, Tortella BJ, Candrilli SD. The direct economic burden of blunt and penetrating trauma in a managed care population. Poster presented at the American Association for the Surgery of Trauma Annual Meeting; September 30, 2006. New Orleans, LA.

Appt SE, Clarkson TB, Lees CJ, Anthony MS. Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys. Maturitas. 2006 Sep 20;55(2):187-94.